Association of VEGF Gene Polymorphisms with Diabetic Retinopathy in a South Indian Cohort

REFERENCES

• Aiello L P, Avery R L, Arrigg P G, Keyt B A, Jampel H D, Shah S T, Pasquale L R, Thieme H, Iwamoto M A, Park J E, Nguyen H V, Ferrara H V, King G L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331: 1519–1520
   PubMed Web of Science ®Google Scholar
• Poulaki V, Joussen A M, Mitsiades N, Mitsiades C S, Iliaki E F, Adamis A P. Insulin-Like Growth Factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol. 2004; 165: 457–469
   PubMed Web of Science ®Google Scholar
• Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis A P. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101(6)1219–1224
   PubMed Web of Science ®Google Scholar
• Chiarelli F, Santilli F, Mohn A. role of growth factors in the development of diabetic complications. Horm Res. 2000; 53: 53–67
   PubMedGoogle Scholar
• Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthal. 2002; 134: 348–353
   PubMed Web of Science ®Google Scholar
• Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes J C, Abraham J A. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991; 266: 11947–11954
   PubMed Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A Common 936 C/T Mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000; 37: 443–448
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund S L, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motorneurons against ischemic death. Nat. Genet. 2003; 34: 383–394
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Devriendt K, Driscoll D A, Goldmuntz E, Gewillig M, Vlietinck R, Collen D, Carmeliet P. Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study (Letter). J Med Genet. 2005; 42: 519–522
   Google Scholar
• Howell W M, Ali S, Rose-Zerilli M J, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet. 2005; 42: 485–490
   PubMed Web of Science ®Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi G P. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol. 2005; 57: 373–380
   PubMed Web of Science ®Google Scholar
• Jacobs E J, Feigelson H S, Bain E B, Brady K A, Rodriguez C, Stevens V L, Patel A V, Thun M J, Calle E E. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006; 8(2)R22, Epub 2006 Apr 13
   PubMed Web of Science ®Google Scholar
• Vannay A, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A, Hajdú J, Tulassay T, Vásárhelyi B. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Paediatric Res 2005; 57(3)396–398
   PubMed Web of Science ®Google Scholar
• Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. A common polymorphism in the 5-prime-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635–1639
   PubMed Web of Science ®Google Scholar
• Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P. Association of VEGF eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis. 2006; 12: 336–341
   PubMed Web of Science ®Google Scholar
• Rani P K, Raman R, Agarwal S, Paul P G, Uthra S, Margabandhu G, et al. Diabetic retinopathy screening model for rural population: Awareness and screening methodology. Rural Remote Health 2005; 5(4)350
   PubMedGoogle Scholar
• Agarwal S, Raman R, Paul P G, Rani P K, Uthra S, Gayathree R, et al. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): Study design and research methodology. Ophthalmic Epidemiol 2005; 12(2)143–153
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B EK, Magli Y L, Brothers R J, Meuer S M, Moss S E, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986; 93: 1183–1187
   PubMed Web of Science ®Google Scholar
• Flanagin A. Who wrote the Declaration of Helsinki?. JAMA 1997; 277: 926
   Google Scholar
• Wolff R, Gemmil R. Purifying and Analysing Genomic DNA. Genome Analysis: A Laboratory Manual. Vol. 4, B Bruce, E D Green, P Hieter, S Klaplholz, R M Myeres, H Riethman. Cold Spring Harbour Laboratory Press, New York 1998; 1–82
   Google Scholar
• Ray D, Mishra M, Ralph S, Read Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004; 53: 861–864
   PubMed Web of Science ®Google Scholar
• Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, Inoue I, Kawasaki I, Mori K, Yoneya S, Katayama S. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 2005; 333: 679–685
   PubMed Web of Science ®Google Scholar